Sebastian Havervall
6PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 27, 2023
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.Oscar Bladh, Nina Greilert-Norin, Sebastian Havervall
|Sep 14, 2022
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.Sebastian Havervall, Ulrika Marking, Julia Svensson
|Apr 21, 2022
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.Sebastian Havervall, Ulrika Marking, Nina Greilert-Norin
|Mar 26, 2022
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.Ulrika Marking, Sebastian Havervall, Nina Greilert-Norin
|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.Sebastian Havervall, Henry Ng, August Jernbom Falk
|Jul 23, 2021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.Sophia Hober, Cecilia Hellström, Jennie Olofsson
Pageof 1
Frequent Collaborators
6 joint publications
Jonas Klingström
4 joint publications
Sophia Hober
4 joint publications
Peter Nilsson
2 joint publications
Jennie Olofsson
2 joint publications
Henry Ng
2 joint publications
August Jernbom Falk
2 joint publications
Jamil Yousef
2 joint publications
Charlotte Thålin
2 joint publications
Anna Månberg
2 joint publications
Elisa Pin
